Skip to main content
. 2023 Sep 5;14(9):590. doi: 10.1038/s41419-023-06092-5

Fig. 4. Lenvatinib inhibits ICC cell migration, invasion, and EMT.

Fig. 4

A, B RTCA confirmed that lenvatinib inhibited the proliferation of OZ and RBE cells. C, D Lenvatinib inhibited the migration and invasion of OZ and RBE cells. E, F The expression levels of E-cadherin and N-cadherin in OZ and RBE cells were detected by Western blotting. G Establishment of the model diagram of the ICC-PDX model. H CT images of tumors in ICC patients. I, J Hematoxylin-eosin staining analysis showed that the PDX model tumor were homologous to the patient’s tumor. KM Tumor volume and tumor weight changed after lenvatinib treatment. N E-cadherin and N-cadherin protein expression in the PDX model was detected by Western blotting. *p < 0.05, ***p < 0.001, and ****p < 0.0001.